Tyler S D, Johnson W M, Lior H, Wang G, Rozee K R
National Laboratory for Special Pathogens, Laboratory Centre for Disease Control, Tunney's Pasture, Ottawa, Ontario, Canada.
J Clin Microbiol. 1991 Jul;29(7):1339-43. doi: 10.1128/jcm.29.7.1339-1343.1991.
A set of synthetic oligonucleotide primers was designed for use in a polymerase chain reaction protocol to specifically detect the B subunit genes in vtx2ha and vtx2hb, which code for the production of the VT2 (Shiga-like toxin II) variant cytotoxins VT2v-a and VT2v-b, respectively. An additional set of primers amplified a fragment common to the B subunits of the VT2 and the VT2 variant genes. Subsequent restriction endonuclease digestion of this amplicon permitted prediction of specific VT2 and variant genotypes on the basis of predetermined restriction fragment length polymorphisms. Genotypes of 21 VT2-producing strains of Escherichia coli were determined using this polymerase chain reaction-restriction fragment length polymorphism procedure. Four strains contained B subunit target sequences only for VT2 genes, 9 strains contained sequences only for VT2v-a genes, and 3 strains contained sequences only for VT2v-b. For genes in combination, one strain contained B subunit genes for both VT2 and VT2v-a and two strains contained B subunit genes for VT2 and VT2v-b. Two strains of E. coli O91:H21 contained both VT2v-a and VT2v-b B subunit genes. The VT2 reference strain of E. coli, E32511, was found to contain the targeted sequences from both VT2 and VT2v-a genes, whereas the recombinant E. coli, pEB1, possessed only that of the VT2 gene. The specific activities of extracellular VT2 determined in HeLa cells ranged from 0.3 to 41.7 TCD50 per microgram of protein in strains carrying the VT2 gene target and from 0 to 50.0 TCD50 per microgram of protein in strains carrying only the VT2 variant target (TCD50 is the tissue culture dose by which 50% of the cells were affected), suggesting that phenotypic expression does not correlate with genotype.
设计了一组合成寡核苷酸引物,用于聚合酶链反应方案,以特异性检测vtx2ha和vtx2hb中的B亚基基因,这两个基因分别编码VT2(志贺样毒素II)变体细胞毒素VT2v-a和VT2v-b的产生。另一组引物扩增了VT2和VT2变体基因B亚基共有的片段。随后对该扩增子进行限制性内切酶消化,可根据预先确定的限制性片段长度多态性预测特定的VT2和变体基因型。使用这种聚合酶链反应-限制性片段长度多态性程序确定了21株产VT2的大肠杆菌的基因型。4株菌株仅含有VT2基因的B亚基靶序列,9株菌株仅含有VT2v-a基因的序列,3株菌株仅含有VT2v-b基因的序列。对于组合基因,1株菌株含有VT2和VT2v-a的B亚基基因,2株菌株含有VT2和VT2v-b的B亚基基因。两株大肠杆菌O91:H21同时含有VT2v-a和VT2v-b B亚基基因。发现大肠杆菌的VT2参考菌株E32511同时含有VT2和VT2v-a基因的靶向序列,而重组大肠杆菌pEB1仅含有VT2基因的靶向序列。在携带VT2基因靶标的菌株中,在HeLa细胞中测定的细胞外VT2的比活性为每微克蛋白质0.3至41.7 TCD50,而在仅携带VT2变体靶标的菌株中为每微克蛋白质0至50.0 TCD50(TCD50是使50%的细胞受到影响的组织培养剂量),这表明表型表达与基因型不相关。